Tag Archives: GlycoMimetics

CFO Magazine: On the IPO On-Ramp

lab_tech

CFO Magazine highlighted the impact of the Jumpstart Our Business Startups (JOBS) Act on smaller companies aiming to obtain access to capital and the benefits of the JOBS Act by highlighting case studies from companies that went public using it. “Nearly everyone agrees that the JOBS Act has significantly affected the way IPOs are done,” writes Edward Teach. Teach talked to five companies to discuss their experiences, and not surprisingly, ‘all had strong opinions about Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Why We Do This Work

rachel-king

In her keynote remarks delivered yesterday at the 2014 BIO International Convention, Rachel King, president & CEO of GlycoMimetics and chairperson of the board of the Biotechnology Industry Organization (BIO), talked about why entrepreneurs pursue opportunities in biotechnology and what sustains these industry leaders through the rollercoaster of raising money, clinical trials, road shows and all the ups and downs of bringing medical innovations from the lab to the bedside. “Working in biotechnology today, we Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Sickle Cell Anemia: Three ways to help end it

SickleCellAnemia

Sickle Cell Anemia is the most common genetic disease in the United States. It affects more than 80,000 people in America and the trait for the disease is known to be carried by one in 12 African Americans. For those living with the disease, suffering from a sickle cell crisis can be debilitating, reducing a person into a state of intense pain, which often means trips to the hospital that typically last six days. There Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,